common side effects of ribatab
hemolytic anemia
hemoglobin
insomnia
dyspnea
lack of concentration
emotional lability
irritability
other side effects
nervousness
comprehensive list of adverse effects
other dosage forms:
needed effects
ribavirin
active ingredient
ribatab
unwanted side effects
medical attention
following side effects
taking ribavirin
check
doctor
ribavirin side effects
medical attention
body
medicine
side effects
health care professional
side effects
following side effects
life-threatening side effects
ribavirin
active ingredient
ribatab
tablets in combination with peginterferon alfa-a
depression
suicide
relapse of drug abuse/overdose
bacterial infections in less
patients
hepatic decompensation
chronic hepatitis c
chc
hiv
coinfected patients
common serious side effect in chc
chc-hiv
patients
receiving peginterferon alfa-a
combination with ribavirin tablets
bacterial infection
sepsis
osteomyelitis
endocarditis
pyelonephritis
pneumonia
common side effects
chc-hiv
coinfected patients
receiving ribavirin tablets in combination with peginterferon alfa-a
neutropenia
anemia
thrombocytopenia
weight decrease
mood alteration
common side effects
patients
receiving ribavirin
capsules/oral solution in combination with peginterferon alfa-b
interferon alfa-b
injection site inflammation/reaction
fatigue/asthenia
headache
rigors
fevers
nausea
myalgia
anxiety/emotional lability/irritability
common serious side effects
peginterferon alfa-b in combination with ribavirin
capsules/oral solution
depression
suicidal ideation in less
patients
common fatal side effects
patients
receiving peginterferon alfa-b in combination with ribavirin
capsules/oral solution
cardiac arrest
suicidal ideation
suicide attempt in less
patients
ventilated patients
respiratory deterioration
severe hypoxia
case report of a
healthy infant
dramatic drop in transcutaneous oxygen within minute
receiving ribavirin
active ingredient
ribatab
oxygen levels
following discontinuation of therapy
infant
postmortem examination
high pulmonary arterial pressure
patent ductus arteriosus
definitive causal relationship
equipment failure
authors
most signs
symptoms
exposed health care workers
minutes
hours
stopping
stopping close exposure
aerosolized ribavirin
respiratory side effects
oral ribavirin in combination with peginterferon alfa-a
peginterferon alfa-b
interferon alfa-b
dyspnea
cough
exertional dyspnea
pharyngitis
rhinitis
sinusitis
ribavirin
capsules/oral solution in combination with peginterferon alfa-b
interferon alfa-b
pulmonary symptoms
including dyspnea
pulmonary infiltrates
pneumonitis
pulmonary hypertension
pneumonia
fatal pneumonia
sarcoidosis
exacerbation of sarcoidosis
oral ribavirin in combination with alpha interferon
pulmonary hypertension
postmarketing experience with ribavirin
capsules/oral solution in combination with interferon alfa-b
peginterferon alfa-b
significant deterioration of pulmonary function in patients with chronic obstructive pulmonary disease
asthma
minor pulmonary function abnormalities in healthy volunteers
aerosolized ribavirin
asthmatic patients
reported dyspnea
chest soreness with aerosolized ribavirin
respiratory status
bronchospasm
hypoventilation
cyanosis
dyspnea
bronchoconstriction
bacterial pneumonia
cough
pneumothorax
pulmonary edema
apnea
atelectasis
hypoxia
ventilator dependence
aerosolized ribavirin
rhinitis
pharyngitis
several cases of bronchospasm
chest pain
individuals
underlying
underlying reactive airway disease
health care workers
aerosolized ribavirin
hypersensitivity side effects
reactions
urticaria
angioedema
bronchoconstriction
anaphylaxis in patients
alfa interferon
ribavirin
active ingredient
ribatab
severe skin reactions
including
vesiculobullous eruptions
stevens-johnson syndrome
erythema multiforme
exfoliative dermatitis/erythroderma
patients
peginterferon alfa-a
combination with ribavirin tablets
serious skin reactions
postmarketing experience in patients
peginterferon alfa-a
dermatologic side effects
rash
skin irritation from prolonged drug contact
alopecia
pruritus
dermatitis
dry skin
sweating
rash
eczema
oral ribavirin
active ingredient
ribatab
combination with peginterferon alfa-a
peginterferon alfa-b
interferon alfa-b
grover
disease
year-old man weeks after the start of ribavirin therapy
photoallergic skin reaction
months after initiation of ribavirin treatment
hours after reexposure
ribavirin
skin disorders
ribavirin tablets in combination with peginterferon alfa-a
lichenoid eruptions
maculopapular rashes
rash
patients
health care workers
aerosolized ribavirin
stevens-johnson syndrome
toxic epidermal necrolysis
postmarketing experience with ribavirin tablets in combination with peginterferon alfa-a
grover
disease
suprabasal transient acantholytic dermatosis
ribavirin use
drug rechallenge in a
year-old man with chronic active hepatitis c.
rash
aerosolized ribavirin
hours
stopping treatment in patients
minutes
hours
stopping
stopping close exposure in health care workers
cardiovascular
side effects
angina
arrhythmia
pulmonary embolism in less
patients
peginterferon alfa-a
combination with ribavirin
active ingredient
ribatab
tablets
nonfatal myocardial infarctions
patients with anemia
ribavirin
capsules/oral solution
cardiac arrest
hypotension
bradycardia
bigeminy
tachycardia
hypertension
slight increases in blood pressure
digitalis toxicity
aerosolized ribavirin
bigeminy
bradycardia
tachycardia
patients
underlying
underlying congenital heart disease
hematologic side effects
oral ribavirin
active ingredient
ribatab
combination with peginterferon alfa-a
peginterferon alfa-b
interferon alfa-b
anemia
lymphopenia
neutropenia
thrombocytopenia
leukopenia
hemolytic anemia
significant toxicity of ribavirin
aplastic anemia
thrombotic thrombocytopenic purpura
patients
peginterferon alfa-a
combination with ribavirin tablets
pancytopenia
marked decreases in red blood cells
neutrophils
platelets
bone marrow suppression
been reported following
been reported following concomitant administration
pegylated interferon
oral ribavirin
azathioprine
aplastic anemia
postmarketing experience with ribavirin
capsules/oral solution in combination with interferon alfa-b
peginterferon alfa-b
pure red cell aplasia
postmarketing experience with oral ribavirin in combination with peginterferon alfa-a
peginterferon alfa-b
interferon alfa-b
cases of anemia
type
reticulocytosis
hemolytic anemia
aerosolized ribavirin
postmarketing experience
drug discontinuation
hemolytic anemia
primary toxicity of ribavirin therapy
hemoglobin levels
weeks of oral therapy
pulmonary adverse effects
anemia
patients
hemoglobin
g/dl
patients
receiving ribavirin tablets in combination with peginterferon alfa-a
additional laboratory abnormalities during treatment with ribavirin tablets in combination with peginterferon alfa-a
interferon alfa-b
decreased neutrophils
cells/mm
cells/mm
cells/mm
platelets
cells/mm
cells/mm
hemoglobin
g/dl
g/dl
changes in laboratory values during treatment with ribavirin
capsules/oral solution in combination with peginterferon alfa-b
interferon alfa-b
decreased hemoglobin
g/dl
g/dl
g/dl
leukocytes
l
l
l
neutrophils
l
l
l
l
platelets
l
l
l
l
ocular side effects
oral ribavirin
active ingredient
ribatab
combination with peginterferon alfa-a
peginterferon alfa-b
interferon alfa-b
blurred vision
corneal ulcer
patients
peginterferon alfa-a
combination with ribavirin tablets
conjunctivitis
ribavirin
capsules/oral solution in combination with peginterferon alfa-b
interferon alfa-b
serous retinal detachment
postmarketing experience with oral ribavirin in combination with peginterferon alfa-a
interferon alfa-b
peginterferon alfa-b
eye irritation
conjunctivitis
patients
health care workers
aerosolized ribavirin
lacrimation
health care workers
aerosolized ribavirin
damage
lenses after prolonged close exposure
aerosolized ribavirin
conjunctivitis
aerosolized ribavirin
hours
stopping treatment in patients
most signs
symptoms
exposed health care workers
minutes
hours
stopping
stopping close exposure
aerosolized ribavirin
eye
conjunctival irritation
caregivers
hospital
cases
caregivers
wearing contact lenses
staff
wearing contact lenses
caring for patients
receiving aerosolized ribavirin
reactions
most signs
symptoms
exposed health care workers
minutes
hours
stopping
stopping close exposure
aerosolized ribavirin
active ingredient
ribatab
gastrointestinal side effects
oral ribavirin in combination with peginterferon alfa-a
peginterferon alfa-b
interferon alfa-b
nausea
nausea
vomiting
diarrhea
vomiting
abdominal pain
dry mouth
dyspepsia
constipation
peptic ulcer
gastrointestinal bleeding
pancreatitis
colitis
patients
peginterferon alfa-a
combination with ribavirin tablets
nausea
health care workers
aerosolized ribavirin
musculoskeletal side effects
oral ribavirin
active ingredient
ribatab
combination with peginterferon alfa-a
peginterferon alfa-b
interferon alfa-b
myalgia
arthralgia
musculoskeletal pain
pain
myositis
patients
peginterferon alfa-a
combination with ribavirin tablets
least cases of mild
moderate gout
ribavirin
capsules/oral solution in combination with peginterferon alfa-b
interferon alfa-b
nervous system
side effects
oral ribavirin
active ingredient
ribatab
combination with peginterferon alfa-a
peginterferon alfa-b
interferon alfa-b
headache
dizziness
excluding vertigo
memory impairment
peripheral neuropathy
coma
cerebral hemorrhage
patients
peginterferon alfa-a
combination with ribavirin tablets
taste perversion
ribavirin
capsules/oral solution in combination with peginterferon alfa-b
interferon alfa-b
hearing impairment
hearing loss
postmarketing experience with ribavirin tablets in combination with peginterferon alfa-a
vertigo
hearing disorder
postmarketing experience with ribavirin
capsules/oral solution in combination with interferon alfa-b
peginterferon alfa-b
headache
dizziness
health care workers
aerosolized ribavirin
seizures
experimental intravenous ribavirin
most signs
symptoms
exposed health care workers
minutes
hours
stopping
stopping close exposure
aerosolized ribavirin
metabolic side effects
oral ribavirin
active ingredient
ribatab
combination with peginterferon alfa-a
peginterferon alfa-b
interferon alfa-b
anorexia
weight decrease
diabetes mellitus
patients
peginterferon alfa-a
combination with ribavirin tablets
low hemoglobin ac levels
dehydration
postmarketing experience with ribavirin tablets in combination with peginterferon alfa-a
diabetes
postmarketing experience with ribavirin
capsules/oral solution in combination with interferon alfa-b
peginterferon alfa-b
low hemoglobin ac levels
ribavirin-induced hemolysis
number
circulating
circulating glycosylated hemoglobin molecules
psychiatric side effects
oral ribavirin
active ingredient
ribatab
combination with peginterferon alfa-a
peginterferon alfa-b
interferon alfa-b
irritability/anxiety/nervousness
emotional lability
insomnia
depression
concentration impairment
mood alteration
agitation
suicide
suicidal ideation
psychosis
aggression
anxiety
drug abuse/overdose
psychotic disorder
hallucination
patients
peginterferon alfa-a
combination with ribavirin tablets
impairment of desire
sexual satisfaction
ribavirin tablets in combination with peginterferon alfa-a in male patients
endocrine side effects
oral ribavirin
active ingredient
ribatab
combination with peginterferon alfa-a
peginterferon alfa-b
interferon alfa-b
hypothyroidism
other side effects
ribavirin
active ingredient
ribatab
tablets in combination with peginterferon alfa-a
influenza-like symptoms
fatigue
pyrexia
myalgia
headache
rigors
fatigue/asthenia
pyrexia
rigors
chills
influenza-like illness
unspecified pain
right upper quadrant pain
pain
chest pain
malaise
oral ribavirin in combination with peginterferon alfa-a
peginterferon alfa-b
interferon alfa-b
hyperuricemia
association with hemolysis
flushing
ribavirin
capsules/oral solution in combination with peginterferon alfa-b
interferon alfa-b
asthenia
experimental intravenous ribavirin
hepatic side effects
hepatic dysfunction
fatty liver
cholangitis in less
patients
peginterferon alfa-a
combination with ribavirin
active ingredient
ribatab
tablets
hepatic decompensation
chc-hiv
coinfected patients
receiving peginterferon alfa-a in combination with ribavirin tablets
hyperbilirubinemia
association with hemolysis
alt
ribavirin
capsules/oral solution in combination with peginterferon alfa-b
interferon alfa-b
changes in laboratory values during treatment with ribavirin
capsules/oral solution in combination with peginterferon alfa-b
interferon alfa-b
increased total bilirubin
mg/dl
mg/dl
mg/dl
alt
x baseline
baseline
immunologic side effects
peginterferon alfa-a
combination with ribavirin
active ingredient
ribatab
tablets
bacterial infection
sepsis
osteomyelitis
endocarditis
pyelonephritis
pneumonia
chc
chc-hiv patients
autoimmune phenomena
hyperthyroidism
hypothyroidism
sarcoidosis
systemic lupus erythematosus
rheumatoid arthritis
patients
resistance mechanism disorders
overall
including
viral infection
fungal infection
oral ribavirin in combination with peginterferon alfa-a
peginterferon alfa-b
interferon alfa-b
liver
renal graft rejections
postmarketing experience with ribavirin tablets in combination with peginterferon alfa-a
genitourinary side effects
ribavirin
active ingredient
ribatab
tablets in combination with peginterferon alfa-a
sexual dysfunction in male patients
menstrual disorder
ribavirin
capsules/oral solution in combination with peginterferon alfa-b
interferon alfa-b
local side effects
injection site reactions
patients
oral ribavirin
active ingredient
ribatab
combination with interferon alfa-b
peginterferon alfa-b
peginterferon alfa-a
injection site inflammation
ribavirin
capsules/oral solution in combination with peginterferon alfa-b
interferon alfa-b
skin disorders
ribavirin tablets in combination with peginterferon alfa-a
cutaneous necrosis at peginterferon
alfa-a injection sites
hyperpigmentation around/over peginterferon
alfa-a injection sites
side effects of ribatab
fda
healthcare professional for medical advice
inhalation powder for solution
anxiety
black, tarry stools
body aches
pain
chest pain
congestion
cough or hoarseness
crying
depersonalization
diarrhea
breathing
discouragement
dry mouth
dryness of the throat
dysphoria
euphoria
feeling
feeling unusually cold
fever or chills
general feeling of discomfort
illness
headache
hyperventilation
irregular heartbeats
irritability
joint pain
lack of appetite
loss of interest
pleasure
side pain
mental depression
muscle aches
pains
nausea
nervousness
difficult urination
pale skin
paranoia
poor concentration
rapidly changing moods
restlessness
stomach pain
runny nose
shaking
shivering
shortness of breath
sleeplessness
sore throat
sores
ulcers
white spots on the lips
mouth
sweating
tender
swollen glands in the neck
tightness in the chest
trouble with concentrating
trouble with sleeping
trouble with swallowing
troubled breathing with exertion
unable to sleep
unusual bleeding
bruising
unusual tiredness
weakness
voice changes
vomiting
wheezing
bleeding gums
blood in the urine
stools
constipation
depressed mood
dry skin
hair
feeling cold
hair loss
husky voice
muscle cramps
stiffness
red spots on the skin
stomach fullness
slowed heartbeat
weight gain
blistering
flaking
peeling of the skin
acid
sour stomach
being forgetful
belching
blurred vision
bone pain
change in taste
taste
cracked, scaly skin
crusting
irritation
itching
reddening of the skin
difficulty with moving
dizziness or lightheadedness
feeling of constant movement of self
surroundings
hair loss
thinning of the hair
heartburn
indigestion
lack
loss of strength
menstrual changes
pain
tenderness around the eyes
cheekbones
rash
sensation of spinning
sneezing
stomach discomfort
pain
stuffy nose
swelling
swollen joints
weight loss
back pain
burning
itching eyes
discharge, excessive tearing
feeling of warmth
redness of the face
neck
arms
upper chest
redness
pain
swelling of the eye
eyelid
inner lining of the eyelid
skin rash
oozing
change in hearing
loss of hearing